default author photo

Syed Muhammad Umer Abdullah

The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases

SCHOLARLY PAPERS

2

DOWNLOADS

546

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Boosting of Serum Neutralizing Activity Against the Omicron Variant Among Recovered COVID-19 Patients by BNT162b2 and Coronavac Vaccines

Number of pages: 36 Posted: 08 Feb 2022
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Li Ka Shing Faculty of Medicine, Princess Margaret Hospital - Department of Medicine, The University of Hong Kong, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, Southern Medical University - Division of Laboratory Medicine, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - School of Clinical Medicine and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 421 (172,704)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Omicron variant, Neutralizing antibody, Surrogate neutralizing antibody test, spike protein receptor binding domain, Variants of Concern

2.

Immune Imprinting with Ancestral SARS-CoV-2 Strain Induced Potent Neutralizing Activity Against Omicron Sublineages BA.2, BA.2.12.1 and BA.4/5

Number of pages: 24 Posted: 01 Sep 2022
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - School of Clinical Medicine and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 125 (576,708)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Omicron variant, BA.2.12.1, BA.4, BA.5 sublineages, immune imprinting, vaccine, neutralizing antibody, hybrid immunity